Brawn Biotech Limited (BOM:530207)

Market Cap	68.11M -1.9%
Revenue (ttm)	172.59M +13.6%
Net Income	8.59M
EPS	2.90
Shares Out	3.00M
PE Ratio	7.83
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	59
Open	23.80
Previous Close	22.70
Day's Range	23.40 - 23.80
52-Week Range	17.71 - 24.37
Beta	0.16
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About Brawn Biotech

Brawn Biotech Limited engages in the trading of pharmaceutical products in India. It provides pharmaceutical formulations, including antibacterial, cardiovascular, antidiabetic, analgesic, gastrointestinal, antifungal, skin care, antipsychotic, antiasthmatic, antacid, antimalarial, and nutritional products. The company was formerly known as Brawn Pharmaceuticals Limited and changed its name to Brawn Biotech Limited in November 2010. The company was incorporated in 1985 and is based in New Delhi, India.

• Industry: Pharmaceutical Preparations
• Founded: 1985
• Employees: 9
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 530207

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 7, 2026

Data Sources Report a data error